| Product NDC: | 65847-205 |
| Proprietary Name: | NATRECOR |
| Non Proprietary Name: | NESIRITIDE |
| Active Ingredient(s): | 1.5 mg/5mL & nbsp; NESIRITIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65847-205 |
| Labeler Name: | Scios Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020920 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20010801 |
| Package NDC: | 65847-205-25 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (65847-205-25) > 5 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 65847-205-25 |
| Proprietary Name | NATRECOR |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (65847-205-25) > 5 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 65847-205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | NESIRITIDE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20010801 |
| Marketing Category Name | NDA |
| Labeler Name | Scios Inc. |
| Substance Name | NESIRITIDE |
| Strength Number | 1.5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Natriuretic Peptide [EPC],Natriuretic Peptides [Chemical/Ingredient] |